Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies

References

• Alfred GG. 2001. Antineoplastic agents. In: Hardman JG, Limbird LE, Eds. The Pharmacological Basis of Therapeutics. New York: McGraw-Hill Publisher, pp. 1432–1434.
   Google Scholar
• Augey V, Cociglio M, Galtier M, Yearoo R, Pinsani V, Bressolle F. 1995. High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum (II) in plasma ultrafiltrate. J Pharm Biomed Anal. 13:1173–1178.
   PubMed Web of Science ®Google Scholar
• Bronaugh RL, Stewart RF, Congdon ER. 1982. Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol Appl Pharmacol. 62:481–488.
   PubMed Web of Science ®Google Scholar
• Bronaugh RL, Stewart RF. 1985. Methods for in vitro percutaneous absorption studies IV: The flow-through diffusion cell. J Pharm Sci. 74:64–67.
   PubMed Web of Science ®Google Scholar
• Calabrese EJ. 1984. Gastrointestinal and dermal absorption: interspecies differences. Drug Metab Rev. 15:1013–1032.
   PubMed Web of Science ®Google Scholar
• Chilcott RP, Dalton CH, Hill I, Davison CM, Blohm KL, Clarkson ED, Hamilton MG. 2005. In vivo skin absorption and distribution of the nerve agent VX (O-ethyl-S-[2(diisopropylamino) ethyl] methylphosphothioate) in the domestic white pig. Hum Exp Toxicol. 24:347–352.
   PubMed Web of Science ®Google Scholar
• Dalton CH, Hattersley IJ, Rutter SJ, Chilcott RP. 2006. Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methyl phosphonothioate) through pig, human and guinea pig skin in vitro. Toxicol In Vitro. 20:1532–1536.
   PubMed Web of Science ®Google Scholar
• Dick IP, Scott RC. 1992. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol. 44:640–645.
   PubMed Web of Science ®Google Scholar
• Dorandeu F, Mikler JR, Thiermann H, Tenn C, Davidson C, Sawyer TW, et al. 2007. Swine model in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology. 233:128–144.
   PubMed Web of Science ®Google Scholar
• Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. 2002. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm. 242:381–84.
   PubMed Web of Science ®Google Scholar
• Gupta V, Agrawal RC, Trivedi P. 2011. Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma. Acta Pharm. 61:63–71.
   PubMed Web of Science ®Google Scholar
• Gupta V, Karthikeyan C, Trivedi P. 2012. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation. Arch Pharm Res. 35:851–859.
   PubMed Web of Science ®Google Scholar
• Gupta V, Trivedi P. 2012. Enhancement of storage stability of cisplatin-loaded protransfersome topical drug delivery system by surface modification with block copolymer and gelling agent. J Drug Del Sci Tech. 22:361–366.
   Web of Science ®Google Scholar
• Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, Li S. 2012. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm. 439:349–357.
   PubMed Web of Science ®Google Scholar
• Jacobi U, Kaiser M, Toll R, Mangelsdorf S, Audring H, Otberg N, et al. 2007. Porcine ear skin: an in vitro model for human skin. Skin Res Technol. 13:19–24.
   PubMed Web of Science ®Google Scholar
• Jain S, Sapre R, Tiwary AK, Jain NK. 2005. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation. AAPS PharmSciTech. 6:513–522.
   PubMed Web of Science ®Google Scholar
• Jain S, Sapre R, Umamaheshwari RB, Jain NK. 2003. Protransfersomes for effective transdermal delivery of norgestrel preparation and in vitro characterization. Indian J Pharm Sci. 65:152–161.
   Google Scholar
• Johnson TM, Rowe DE, Nelson BR, Swanson NA. 1992. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 26:467–484.
   PubMed Web of Science ®Google Scholar
• Kim MK, Chung SJ, Lee MH, Shim CK. 1998. Delivery of hydrocortisone from liposomal suspensions to the hairless mouse skin following topical application under non-occlusive and occlusive conditions. J Microencapsul. 15:21–29.
   PubMed Web of Science ®Google Scholar
• Leiter U, Garbe C. 2008. Epidemiology of melanoma and nonmelanoma skin cancer-the role of sunlight. Adv Exp Med Biol. 624:89–103.
   PubMed Web of Science ®Google Scholar
• Lin SY, Hou SJ, Hsu TH, Yeh FL. 1992. Comparisons of different animal skins with human skin in drug percutaneous penetration studies. Methods Find Exp Clin Pharmacol. 14:645–654.
   PubMed Web of Science ®Google Scholar
• Lopez-Flores A, Jurado R, Garcia-Lopez P. 2005. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cells, and tumor samples. J Pharmacol Toxicol Methods. 52:366–372.
   PubMedGoogle Scholar
• Martindale. 2002. Antineoplastics and Immunosuppressants. In: Sweetman SC, Ed. The Complete Drug Reference, Part 1. London: Pharmaceutical Press, p. 494.
   Google Scholar
• Meyer W, Schwarz R, Neurand K. 1978. The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol. 7:39–52.
   PubMedGoogle Scholar
• Monteiro-Riviere N, Riviere JE. 1996. The pig as a model for cutaneous pharmacology and toxicology research. In: Tumbleson ME, Shook LB, Eds. Advances in Swine in Biomedical Research. New York: Plenum Press, pp. 425–458.
   Google Scholar
• Newman MD, Weinberg JM. 2007. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma. Cutis. 79:18–28.
   PubMed Web of Science ®Google Scholar
• Padamwar MN, Pokharkar VB. 2006. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Int J Pharm. 320:37–44.
   PubMed Web of Science ®Google Scholar
• Panchagnula R, Stemmer K, Ritschel WA. 1997. Animal models for transdermal drug delivery methods and findings. Exp Clin Pharmco. 19:335–341.
   Web of Science ®Google Scholar
• Price NM. 2007. The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams. J Drugs Dermatol. 6:778–781.
   PubMedGoogle Scholar
• Puglia C, Trombetta D, Venuti V, Saija A, Bonina F. 2004. Evaluation of in vivo topical anti-inflammatory activity of indomethacin from liposomal vesicles (LUV). J Pharm Pharmacol. 56:1225–1232.
   PubMed Web of Science ®Google Scholar
• Sabitha M, Sanoj Rejinolda N, Naira A, Lakshmanan VK, Nair SV, Jayakumar R. 2013. Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydr Polym. 91:48–57.
   PubMed Web of Science ®Google Scholar
• Sato K, Sugibayashi YM. 1991. Species differences in percutaneous absorption of nicorandil. J Pharm Sci. 80:104–107.
   PubMed Web of Science ®Google Scholar
• Schmook FP, Meingassner JG, Billich A. 2001. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm. 215:51–56.
   PubMed Web of Science ®Google Scholar
• Seth AK, Mishra A, Umrigar D. 2004. Topical liposomal gel of idoxuridine for the treatment of herpes simplex: pharmaceutical and clinical implications. Pharm Dev Technol. 9:277–289.
   PubMed Web of Science ®Google Scholar
• Singh R, Vyas SP. 1996. Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci. 13:107–111.
   PubMed Web of Science ®Google Scholar
• Torres A, Storey L, Anders M, Miller RL, Bulbulian BJ, Jin J, et al. (2007). Immune-Mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream. J Transl Med. 26:5–7.
   Google Scholar
• Vallet V, Cruz C, Licausi J, Bazire A, Lallement G, Boudry I. 2008. Percutaneous penetration and distribution of VX using in vitro pig or human excised skin: Validation of demeton-S-methyl as adequate simulant for VX skin permeation investigations. Toxicology. 246:73–82.
   PubMed Web of Science ®Google Scholar
• Vecchia BE, Bunge A. 2006. Animal models: a comparison of permeability coefficients for excised skin from humans and animals. In: Riviere JE, Ed. The Dermal Absorption Models in Toxicology and Pharmacology. CRC Press: Boca Raton, pp. 305–333.
   Google Scholar
• Walker M, Dugard PH, Scott RC. 1983. In vitro percutaneous-absorption studies – A comparison of human and laboratory species. Human Toxicol. 2:561–562.
   Google Scholar
• Yoo HS, Lee KH, Oh JE, Park TG. 2000. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugates. J Control Release. 68:419–431.
   PubMed Web of Science ®Google Scholar